Q1: Which labeling method is best for in vivo biodistribution studies?

For non-invasive in vivo imaging, bioluminescence (Luciferase reporter) and radiolabeling (SPECT/PET) provide the highest sensitivity and quantitative capability. Near-infrared fluorescent dyes (DiR, Cy7) can be used for superficial tissues or optical imaging windows. MRI-based labels (SPIO, Gd) are preferred when anatomical resolution is required. The optimal choice depends on your imaging instrumentation, required depth of detection, and study duration.

Q2: Does labeling affect exosome biological function?

It can, if not properly controlled. Membrane dye labeling at high concentrations can alter lipid bilayer fluidity; NHS-ester conjugation to surface proteins may impair receptor interactions. We mitigate these risks through optimized reagent titration, minimal labeling conditions, and functional validation assays post-labeling. Genetic reporter strategies using endogenous promoter-driven constructs cause minimal perturbation to native EV biology.

Q3: How do you remove unincorporated dye or unconjugated reagent?

We employ a combination of size exclusion chromatography (SEC), ultracentrifugation, and/or magnetic separation depending on the label type. For fluorescent dyes, SEC or ultracentrifugation effectively separates dye-labeled exosomes from free dye micelles. For radiolabeled preparations, ITLC or reversed-phase HPLC is used to verify radiochemical purity. Free biotin is removed by SEC and confirmed by HABA assay.

Q4: Can exosomes be labeled with multiple reporters simultaneously?

Yes. Multi-modal labeling is possible, for example combining a fluorescent membrane dye for microscopy with a near-infrared dye for whole-animal imaging, or pairing a genetic GFP reporter with surface biotin conjugation. We design orthogonal labeling strategies to minimize interference between detection channels.

Q5: What exosome sources are compatible with your labeling services?

Our labeling protocols are compatible with exosomes and extracellular vesicles derived from a wide range of sources, including HEK293T, mesenchymal stem cells, tumor cell lines, primary cells, and milk-derived exosomes. Client-provided exosome preparations are accepted.

Exosome Labeling Services - Creative Biostructure Exosome

Creative Biostructure provides comprehensive exosome labeling services to support biodistribution tracking, imaging, and functional studies in vitro and in vivo. Our solutions enable reliable detection of extracellular vesicles (EVs) across fluorescence microscopy, bioluminescence imaging, radiolabeling-based tracking, MRI/CT contrast imaging, genetic reporter systems, and biotin-mediated downstream applications. Built on validated protocols, rigorous quality control, and deep expertise in EV biology, we deliver precisely labeled exosome preparations tailored to diverse research and industrial needs.

What Is Exosome Labeling

Exosome labeling is the process of introducing detectable markers—such as fluorescent dyes, luminescent enzymes, radioisotopes, magnetic or contrast agents, reporter constructs, or biotin groups—into or onto exosomes for reliable detection. Since native exosomes are nanoscale vesicles with limited intrinsic signal, labeling enables tracking of their biodistribution, cellular uptake, subcellular localization, and pharmacokinetic behavior in complex biological systems.

Common labeling strategies include:

Exogenous labeling: Post-isolation conjugation of dyes, tracers, magnetic agents, or biotin to purified exosomes.
Endogenous labeling: Engineering producer cells to express reporter proteins, such as GFP, or luciferase, fused with exosome-associated proteins.

The optimal strategy depends on the detection platform, sensitivity requirements, experimental model, and intended in vitro or in vivo application.

Why Is Proper Exosome Labeling Critical

Poorly controlled labeling can alter exosome surface chemistry, impair biological function, or generate signal artifacts from free dye or unbound reagents. Rigorous labeling and purification are therefore essential for:

Accurate biodistribution and pharmacokinetic studies
Reliable cellular uptake and trafficking experiments
High-resolution imaging without background interference
Quantitative cargo tracking in therapeutic development pipelines
Multi-modal imaging combining two or more detection strategies

In vivo exosome imaging methods using fluorescent, genetic, radioactive, and nanoparticle labels. Figure 1. Exosome Imaging and Labeling Strategies. (Boudna M, et al., 2024)

Our Exosome Labeling Capabilities

Creative Biostructure provides comprehensive exosome labeling services matched to specific imaging modalities and research goals. For each project, we optimize label selection, reagent concentration, incubation conditions, purification, and quality control to achieve specific signals while preserving exosome integrity.

Service	Key Features	Primary Applications
Exosome Fluorescent Labeling	Membrane, surface, and intraluminal labeling using lipophilic dyes, amine-reactive dyes, antibody–fluorophore conjugates, and multicolor strategies	Confocal and TIRF microscopy, flow cytometry, cellular uptake, co-localization, and single-EV analysis
Exosome Bioluminescent Labeling	Luciferase reporters fused to exosome-enriched proteins such as CD63, CD9, and CD81	Sensitive longitudinal BLI, in vivo biodistribution, clearance, and tissue uptake studies
Exosome Radiolabeling	Direct or chelator-mediated labeling with radionuclides such as ¹²⁵I, ^99mTc, ⁶⁴Cu, and ¹⁸F, with radiochemical purification and QC	Quantitative PET/SPECT imaging, pharmacokinetics, organ distribution, and whole-body tracking
Exosome Magnetic and Contrast Agent Labeling	SPION/USPIO loading, gold nanoparticle labeling, and custom or multimodal contrast-agent strategies	MRI and CT tracking, deep-tissue biodistribution, anatomical localization, and multimodal imaging validation

Standard Workflow

Our standardized workflow ensures consistent execution, rigorous quality control, and transparent project delivery:

Project Consultation & Strategy Design: Define detection modality, sample type, study objectives, and the most suitable labeling approach.
Exosome Preparation & Initial Assessment: Isolate exosomes from specified sources or evaluate client-provided materials using methods such as NTA and Western blot.
Labeling Optimization: Select labeling reagents, conjugation chemistry, reagent concentration, and reaction conditions through small-scale feasibility testing.
Scale-Up Labeling Execution: Perform controlled and reproducible labeling reactions at the target project scale.
Purification & Quality Control: Remove free dyes or unconjugated reagents and characterize labeled exosomes for purity, size, marker expression, and labeling efficiency.
Delivery & Technical Support: Provide labeled exosome preparations with documentation, data summary, and follow-up scientific consultation.

Exosome labeling workflow from consultation and preparation to optimization, scale-up labeling, QC, and delivery support. Figure 2. Project Workflow for Exosome Labeling. (Creative Biostructure)

Quality Control and Characterization

Each labeled exosome preparation is systematically characterized to verify vesicle integrity, labeling performance, purity, and functional suitability.

Particle size and concentration: NTA analysis
Morphology analysis: TEM or Cryo-EM imaging
Surface marker verification: Western blot or flow cytometry for CD63, CD9, CD81, TSG101, and Alix
Labeling efficiency: Fluorescence spectroscopy, radioactivity measurement, HABA assay, or luciferase luminometry
Free label removal: SEC profiling, TLC, or HPLC analysis
Functional integrity: Optional cellular uptake, biodistribution pilot, or receptor binding assay
Purity assessment: Detection of residual cell debris, protein aggregates, or free labeling reagents

Applications

Our labeled exosome preparations support diverse in vitro, in vivo, and preclinical research applications.

Cellular uptake and endocytosis pathway analysis
In vivo biodistribution and pharmacokinetic profiling
Tumor targeting evaluation of engineered exosomes
Intercellular communication and cargo transfer studies
Exosome-based diagnostics and biosensor development
Capture and isolation assays using biotinylated exosomes
Multi-modal imaging with combined labeling strategies
Preclinical safety and distribution studies for drug delivery programs

What Deliverables Will You Receive

Deliverable	Description
Labeled Exosome Samples	Ready-to-use labeled exosomes in appropriate buffer, shipped with dry ice or liquid nitrogen as required
Quality Control Report	Analytical data on size distribution, morphology, surface markers, and labeling efficiency
Experimental Summary	Detailed description of labeling method, reagents, conditions, and purification steps
Analytical Data Files	Raw NTA traces, TEM images, spectroscopy or radioactivity data, Western blot images
Technical Recommendations	Guidance for storage conditions, handling, recommended experimental controls, and downstream use

How to Start Your Project

Starting a labeling project with Creative Biostructure is straightforward. We can work with client-provided exosome preparations or initiate with full exosome isolation from your specified cell source. To get started:

Describe your target labeling modality and downstream application
Provide your exosome samples (or request isolation services) along with basic characterization data
Receive a customized project proposal, timeline, and quotation

Why Choose Creative Biostructure

Multi-modal labeling expertise: Integrated fluorescent, bioluminescent, radiolabeling, and magnetic labeling solutions.
Validated workflows: Optimized protocols help reduce artifacts and support reliable EV tracking.
Label-specific optimization: Reagents, reaction conditions, and purification methods are tailored to each exosome source and labeling modality.
Stringent free-label removal: Dedicated purification ensures signals are primarily exosome-associated.
Comprehensive exosome characterization: Each preparation is assessed for size, purity, marker expression, labeling efficiency, and consistency.

Case Study

Case: In Vivo Biodistribution Tracking of DiR-Labeled Exosomes

Background

Reliable exosome labeling is critical for evaluating delivery efficiency and tissue distribution in preclinical studies. This study used DiR labeling to track exosomes derived from Salmonella-infected macrophages after intranasal administration in mice.

Methods

Exosome source: Salmonella-infected RAW264.7 macrophages
Labeling dye: DiR fluorescent dye
Route: Intranasal administration
Analysis: IVIS imaging, organ fluorescence imaging, lung immunofluorescence, and flow cytometry

Results

DiR-labeled exosomes traced in mouse respiratory tissues after intranasal delivery. Figure 3. DiR labeling enabled visualization of exosome biodistribution in mice, showing respiratory tract and lung localization after intranasal administration, with further validation by organ imaging, lung tissue staining, and immune cell analysis. (Hui W W, et al., 2021)

DiR-labeled exosomes were successfully visualized 24 hours after administration.
Strong fluorescence signals were detected in the upper respiratory tract and lungs.
Free DiR controls helped distinguish true exosome localization from dye background.
Lung tissue analysis confirmed exosome accumulation and immune cell infiltration near pulmonary mucosa.

Conclusion

This case shows that optimized DiR labeling enables reliable in vivo tracking of exosome biodistribution and supports tissue-level validation of exosome delivery.

Looking to improve exosome tracking, imaging sensitivity, or biodistribution analysis? Creative Biostructure offers tailored exosome labeling solutions based on your detection modality, exosome source, and research goals. Contact us to start your project with a customized labeling strategy.

References

Hui W W, Emerson L E, Clapp B, et al. Antigen-encapsulating host extracellular vesicles derived from Salmonella-infected cells stimulate pathogen-specific Th1-type responses in vivo. PLoS Pathogens. 2021, 17(5): e1009465.
Santelices J, Ou M, Hui W W, et al. Fluorescent labeling of small extracellular vesicles (EVs) isolated from conditioned media. Bio-Protocol. 2022, 12(12): e4447-e4447.
Boudna M, Campos A D, Vychytilova-Faltejskova P, et al. Strategies for labelling of exogenous and endogenous extracellular vesicles and their application for in vitro and in vivo functional studies. Cell Communication and Signaling. 2024, 22(1): 171.
Hong S, Jo H C, Kim H L, et al. In vivo exosome imaging: applications of diverse visualization techniques. BMB Reports. 2025, 58(8): 340.

Frequently Asked Questions

For any inquiries, our support team is ready to help you get technical support for your research and maximize your experience with Creative Biostructure.

Related Services